Scientific translation
Clarify target biology, assay evidence, biomarker rationale, and program claims for U.S. technical audiences.
Global biotech innovation, translated for U.S. evaluation
VexisBio helps teams convert promising science into U.S.-ready assay evidence, translational positioning, and partner-facing technical narratives.
Assay credibility
Identify what data, controls, validation planning, and documentation are needed before external review.
Partner readiness
Prepare clear scientific packages for investors, BD teams, collaborators, and diligence conversations.
Where VexisBio fits
We are not just a catalog supplier and not a generic CRO. Our role is to help complex programs cross the gap between technical promise and credible U.S.-facing evaluation.